LDS/Medical Tests/B-cell Activating Factor Receptor (BAFF-R) Gene Mutation Analysis

B-cell Activating Factor Receptor (BAFF-R) Gene Mutation Analysis

Common variable immunodeficiency (CVID) is a primary immunodeficiency syndrome characterized by defective B-cell differentiation resulting in immunoglobulin deficiency. Clinically CVID may present as recurrent infections, chronic lung disease, autoimmune disorders, gastrointestinal disorders and/or an increased risk of developing lymphoma.

B cell-activating factor (BAFF) belongs to the tumor necrosis factor superfamily and is a vital cytokine for B cells survival and maturation. The BAFF exerts its effects by binding to three receptors; transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI), B cell maturation Ag (BCMA) and BAFF-R (BAFF-R/BR3). BAFF-R is normally expressed on over 95% of B cells, while TACI is expressed on a smaller subset of B cells (3%-70%) and some activated T cells

Mutations in the genes encoding B cell-activating factor receptor (BAFF-R have been identified as one of several genetic factors that can cause CVID. BAFF-R is a type III transmembrane protein of 184 amino acids residues and expressed by all surface Ig+ B cells other than plasma cells. It has been demonstrated that binding BAFF-R to BAFF is essential to the development of B cells. Absence or decreased BAFF-R causes dysregulation of B-cell development at the stage of transitional B cells. A BAFF-R defect should be suspected in patients with low to very low numbers of class switched and non-switched memory B cells and very high numbers of transitional B cells. Class switching is the process that allows B cells, which possess IgD and IgM on their cell surface as a part of the antigen-binding complex, to produce IgA, IgE, or IgG antibodies.

A TACI defect is suspected in patients with low IgM levels, normal to low switched B cells, and normal B cell responses to mitogens. Patients with mutations in the TACI gene are particularly prone to developing autoimmune disease, including cytopenias as well as lymphoproliferative disease. The other mutations each have been reported in only a handful of patients. The pathogenesis is still undefined in more than 50% of CVID patients.

Deficient BAFF-R expression is usually identified by flow cytometry; however, molecular diagnosis may be used to detect the responsible mutations. Since the majority of TACI mutations (>95%) preserve protein expression but abrogate protein function, it may be necessary to perform targeted or whole gene sequencing of the TACI gene.

  • As an aid in diagnosis of Common variable immunodeficiency
  • Therapy and disease management
Pathogen variants are reported based on American College of Medical Genetics recommendations. Variants are classified based on known, predicted, or possible pathogenicity and reported with interpretive comments detailing their potential or known significance.

Negative for mutation analysis (No pathogenic mutations detected)

Targeted or whole gene sequencing by Next Generation Sequencing (NGS), Target sequencing by conventional sequencing, other molecular methods.

Whole blood in a lavender top (EDTA) tube, Buccal swabs with appropriate transport media.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
B-cell Activating Factor Receptor (BAFF-R) by flow cytometry.
7-14 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login